Paper Details

  1. Home
  2. Paper Details

Isoetharine versus albuterol for acute asthma: greater immediate effect, but more side effects.

Author: BidadiK, GourlayS, HayesJ, RobertsonS, ShresthaM, WainscottM

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Both isoetharine and albuterol were effective for acute severe asthma, with isoetharine demonstrating a significantly faster onset of action. However, isoetharine was associated with more side effects.
Paper Details　
Original Abstract of the Article :
PURPOSE: To compare the magnitudes of the immediate effects of the nebulized beta-agonists isoetharine and albuterol in the treatment of acute severe asthma. PATIENTS AND METHODS: Fifty-one adults presenting with severe asthma exacerbations (forced expiratory volumes in the first second of exhalati...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/S0002-9343(97)89491-0

データ提供：米国国立医学図書館（NLM）

Isoetharine vs. Albuterol: Navigating the Desert of Asthma Relief

This research compares the effectiveness of two commonly used bronchodilator medications, isoetharine and albuterol, in treating acute asthma. It's like discovering two different paths through a desert, each offering a unique route to relief. The study investigates the immediate and long-term effects of these medications on asthma symptoms, exploring their relative effectiveness and potential side effects.

Isoetharine: A Quick Fix in the Desert of Asthma

The study reveals that isoetharine provided a faster and more significant improvement in lung function compared to albuterol in the initial stages of treatment. It's like finding a shortcut through the desert, offering a quick path to a desired destination. However, this benefit was short-lived, with both medications showing similar effectiveness within an hour of treatment. Despite the initial advantage, isoetharine was also associated with a higher incidence of side effects, highlighting the importance of considering the trade-offs between efficacy and safety.

Navigating the Desert of Asthma Treatment: Finding the Right Path

The study emphasizes the importance of personalized approaches to asthma treatment, considering the individual needs and preferences of patients. It's like recognizing that the best path through the desert depends on the specific challenges and resources available. The findings suggest that while isoetharine may provide faster initial relief, albuterol offers a more balanced approach, balancing effectiveness with safety. It's essential to consult with a healthcare professional to determine the best course of treatment for individual patients.

Dr.Camel's Conclusion

This research explores the effectiveness of two common bronchodilators, isoetharine and albuterol, in treating acute asthma. It's like navigating a desert, recognizing that different paths offer unique advantages and drawbacks. While isoetharine provides quicker initial relief, albuterol offers a more balanced approach, highlighting the importance of personalized care and considering the individual needs of each patient.

Date :
  1. Date Completed 1996-06-27
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

8629678

DOI: Digital Object Identifier

10.1016/S0002-9343(97)89491-0

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.